<DOC>
	<DOCNO>NCT02449070</DOCNO>
	<brief_summary>The purpose study determine whether nicorandil reduce cardiac infarct size patient ST-segment elevation acute myocardial infarction .</brief_summary>
	<brief_title>Effects Nicorandil Cardiac Infarct Size Patients With ST-segment Elevation Acute Myocardial Infarction</brief_title>
	<detailed_description>Study objective : To investiage whether nicorandil treatment reduce infarct size measure cardiac MRI 6 month primary PCI Allocation : 1 . Nicorandil arm : Recieve nicorandil 4 mg i.v . undergoing PCI , additionall 2mg i.c . 1st ballooning , additionall 2mg i.c . stenting , After successful PCI , 10 mg/day ( 5 mg/day ) p.o . 6 month . 2 . Control arm : Recieve standard treatment include PCI , avoid nicoranil adenosine . Follow-up Measurement : Cardiac MRI scan schedule 5 day 6 month primary PCI . Clinically follow upto 6 month parimary PCI .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Nicorandil</mesh_term>
	<criteria>STEMI patient present within 12 hour symptom onset Undergoing primary PCI Previous myocardial infarction Atrial fibrillation RV infarction Cardiogenic shock Serum creatinine &gt; 2.0 mg/dL Narrow angle glaucoma Taking PDE5 inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Nicorandil</keyword>
	<keyword>Cardiac MRI</keyword>
</DOC>